₹325 Crore Quarter Masks a Margin Collapse
Revenue spiked 33.5% YoY to ₹325 Cr, but EBITDA margins compressed to 8.9% from 12.6%, profit fell 9.3% QoQ, and guidance was cut mid-year. The growth is real; the profitability gains are not.
₹18 Cr
Q2 FY27
8.9%
vs 12.6% FY26 · vs ~10% guided
+33.5% YoY
₹325 Cr Q2 | but -4.1% QoQ
10–15%
narrowed from 10–20%
Ardee's Q2 tells two contradictory stories. The headline reads bullish: revenue jumped 33.5% YoY, and the company has added 50,000 MT of new capacity and expanded exports to 80+ countries. But below the line, margins collapsed. EBITDA fell to 8.9% from 12.6% a year ago, profit dropped 9.3% quarter-on-quarter despite the YoY growth, and management cut its full-year guidance from 10–20% to 10–15% — a tacit admission mid-year that the quarter's cost pressures will not ease as hoped. The real story is margin compression, not revenue growth.
Where the profit went
Q2 net profit of ₹18 Cr (5.5% margin) landed cleanly. But the EBITDA shortfall is the problem. Management guided ~10% EBITDA margin for FY27 and delivered 8.9% — a 110-basis-point miss. The culprit is unambiguous: raw material (lead, battery scrap, imported inputs) and OPEX (fuel, wages, utilities) costs spiked due to global supply-chain disruption and the geopolitical environment. Management expects these headwinds to persist 3–4 months longer, implying pressure through at least November/December 2026.
Claims vs. what holds up
Revenue growth 33.5% YoY driven by volume and pricing
EBITDA margins 8.9% in Q2; maintaining ~10% for FY27
50K MT new capacity will enable 70–75% utilization this year
Exports at 37% of revenue; expanding to 80+ countries
Maintaining 10–15% FY27 growth target despite cost headwinds
Verdict on each: The revenue growth is real — H1 FY27 clocked ₹661 Cr vs ₹494 Cr H1 FY26, a 34% jump. But it masks a QoQ decline: Q2 revenue was -4.1% from Q1 (~₹339 Cr implied). Volume is flat YoY (15.7K MT vs 15.6K MT last year). So the YoY growth is driven by pricing and mix, not volume lift — yet the guidance was cut. EBITDA at 8.9% is overstated vs the ~10% target; management cites ongoing inflation and admits no near-term recovery. The 50K MT debtlessnecking and 70–75% utilization are credible long-term ambitions, but the timeline is vague: management said 'probably next year' when asked when it will contribute volumes — a red flag for capex execution risk. Exports are real (₹244 Cr in H1 = 37% of total) and geographic diversification is a genuine hedge. The FY27 guidance cut (10–20% → 10–15%) is an overstatement of confidence; it signals management expects macro headwinds to persist.
What changed on this call
Three downgrades and one upgrade. Management is telegraphing a year of margin pressure and deferred capacity utilization, while the export franchise is becoming genuinely global. The net message: long-term optionality is intact; near-term leverage is absent.
How the street is positioned
The market's verdict has been swift and unforgiving. The stock closed at ₹42.97 on 2026-11-16, down 37.22% from its all-time high of ₹68.44 — a severe drawdown. It is trading below its 20-day SMA (₹44.84), 50-day SMA (₹48.23), and the RSI sits at 38.1 (neutral-to-oversold territory). The tape is not yet capitulating — volume is increasing — but it is repricing the story as a 'low-margin grind' rather than a growth story.
Ownership data (Q2 FY27) shows FII at 0.67% and DII at 5.24% — shallow institutional ownership. Bulk deals in August tell an interesting story: large buys by NK Securities, Two Roads Trading, GRT Ventures, and Vinod Manjibhai Chauhan around ₹69–70 per share (mid-August highs), followed by promotional selling at ₹59 on Aug 14. That sequence — institutional accumulation into weakness, then promoter trimming — suggests insiders are managing the downside and pros are nibbling at the drawdown.
Bull-bear ledger
Bull: 33.5% revenue YoY growth is real; geographic diversification to 80+ countries hedges customer concentration
Bull: 50K MT new capacity and targeting 70–75% utilization offer long-term operating leverage
Bull: Stock down 37% from ATH; institutional accumulation at ₹69–70 suggests value re-entry
Bear: EBITDA margin at 8.9% vs ~10% guided; management admits 3–4 months more cost pressure ahead
Bear: QoQ profit down 9.3% despite YoY growth; volume is flat YoY (15.7K MT). Growth is not sustainable.
Bear: Capacity ramp timing is vague ('probably next year'); capex execution risk unresolved
Bear: Top 7–10 battery manufacturers are dominant customers; loss of one material supplier would crater volumes
Bear: Forex and commodity exposure (LME-linked lead pricing) only 5–10% hedged; volatility ahead
Risks, ranked by how much they should concern a holder
Margin recovery timeline keeps slipping
HighEBITDA is 8.9% vs 10% guided; management expects 3–4 months more cost pressure (through ~Nov/Dec 2026). If inflation persists beyond that, FY27 EBITDA could close at 8–9%, not 10%+. That would trigger another guidance cut and further selloff.
Customer concentration and loss of a top battery manufacturer
HighTop 7–10 battery manufacturers are ~70%+ of revenue. Onboarding a new customer takes 1–1.5 years. Loss of a Chloride or similar would crater volumes; FY27 growth target becomes unachievable.
Capacity ramp misses (50K MT debtlessnecking doesn't contribute as hoped)
HighNew capacity is the lever for 70–75% utilization and margin recovery. If capex execution slips or volumes don't materialize, management will cut guidance again in Q3/Q4 FY27.
Raw material cost inflation persists into 2027
MediumCurrently blaming Ukraine war, fuel costs, LME volatility (₹1,850–1,950/tonne). If geopolitical tension does not ease, EBITDA margin stays under 9% all through FY27–FY28, eroding investor patience.
Forex headwinds from LME lead prices or rupee weakness
MediumOnly 5–10% hedged. Export revenue (37% of sales) is exposed. A sharp ₹/$ move or lead price spike could swing Q3 earnings unpredictably.
The debate
What to watch next
1 · Q3 FY27 EBITDA margin recovery
Management expects cost inflation to ease in 3–4 months. If Q3 EBITDA margin rebounds to ~9.5–10%, the case re-establishes itself and the stock could recover 15–20% by Jan 2027. If it stays at 8–8.5%, another guidance cut is likely and the stock goes lower.
2 · Volume trajectory in H2 FY27
H1 volume was 33.3K MT (on track for ~10% growth). If H2 volume jumps to >17K MT per quarter (vs flat 15.7K MT Q2), management's 10–15% FY27 growth target is credible. If it stays flat, expect another guidance reset.
3 · Concrete capex plans for Nadupeta land (6-acre Andhra Pradesh facility)
Land was allotted but no capex plan shared yet. If management announces a capex budget and timeline for Nadupeta in Q3/Q4, it signals confidence in long-term demand. If it defers again, capex execution risk deepens.
The honest read
Ardee's Q2 is a case study in how headline growth can mask deteriorating fundamentals. Revenue up 33.5% sounds impressive. But margins are compressed, profit fell quarter-on-quarter, guidance was cut, and management admits 3–4 months of cost headwinds remain. This is not a step-change story; it is a steady, margin-pinched grind.
The bull case for FY28+ is intact: new capacity, geographic diversification, and industry tailwinds (EPR formalization, battery recycling growth) are real. But FY27 is a year of patience, not profits. The stock's 37% drawdown from its all-time high has repriced this accurately. A holder should tighten stops and wait for Q3 margin recovery; a buyer should sit out until November 2026 earnings give clarity on cost normalization. The number to track from here is EBITDA margin in Q3 — if it stays under 9%, the margin story is broken, not cyclical.
Rating: Hold / Downgrade to HOLD for growth-chasing buyers.
Informational and educational content only. Not investment advice.